Platelet-endothelial cell adhesion molecule-1 (CD31) recycles and induces cell growth inhibition on human tumor cell lines

Journal of Cellular Biochemistry

Volumn 98, Issue 5, 2006, Pages 1334-1350

  Lutzky, Viviana P ^a   Carnevale, Romina P ^a   Alvarez, Mariano J ^b   Maffia, Pauio C ^a   Zittermann, Sandra I ^a,c   Podhajcer, Osvaldo L ^b   Issekutz, Andrew C ^c   Chuluyan, H Eduardo ^a  

^a HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^b UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^c DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Adenocarcinoma; Apoptosis; CD31; Cell growth; Melanoma; PECAM 1

Indexed keywords

CD31 ANTIGEN;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL MEMBRANE PERMEABILITY; CELL PROLIFERATION; CELL SURVIVAL; CONFOCAL MICROSCOPY; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MULTIGENE FAMILY; PRIORITY JOURNAL; PROTEIN DOMAIN; TUMOR CELL LINE; TUMOR GROWTH; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ANNEXIN A5; ANTIBODIES; ANTIGENS, CD31; CELL COMMUNICATION; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, SERUM-FREE; HUMANS; NEOPLASMS; OLIGONUCLEOTIDES, ANTISENSE;

EID: 33746397518     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20769     Document Type: Article

References (62)

1. Albelda SM, Oliver PD, Romer LH, Buck CA. 1990. EndoCAM: A novel endothelial cell-cell adhesion molecule. J Cell Biol 110:1227-1237.
2. Berman M, Muller W. 1995. Ligation of platelet/endothelial cell adhesion molecule 1 (PECAM-1/CD31) on monocytes and neutrophils increases binding capacity of leukocyte CR3 (CD11b/CD18). J Immunol 154:299-307.
3. Berman ME, Xie Y, Muller WA. 1996. Roles of platelet/ endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and beta 2 integrin activation. J Immunol 156:1515-1524.
4. Bogenrieder T, Herlyn M. 2003. Axis of evil: Molecular mechanisms of cancer metastasis. Oncogene 22:6524-6536.
5. Cefai D, Schneider H, Matangkasombut O, Kang H, Brody J, Rudd CE. 1998. CD28 receptor endocytosis is targeted by mutations that disrupt phosphatidylinositol 3-kinase binding and costimulation. J Immunol 160:2223-2230.
6. Chuluyan HE, Issekutz AC. 1993. VLA-4 integrin can mediate CD11/CD18-independent transendothelial migration of human monocytes. J Clin Invest 92:2768-2777.
7. Clayton LK, Diener AC, Lerner A, Tse AG, Koyasu S, Reinherz EL. 1992. Differential regulation of T-cell receptor processing and surface expression affected by CD3 theta, an alternatively spliced product of the CD3 zeta/eta gene locus. J Biol Chem 267:26023-26030.
8. Cramer E, Berger G, Berndt M. 1994. Platelet α-granule and plasma membrane share two new components: CD9 and PECAM-1. Blood 84:1722-1730.
9. De Young BR, Frierson HFJ, Ly MN, Smith D, Swanson PE. 1998. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol 110:374-377.
10. Deaglio S, Morra M, Mallone R, Ausiello CM, Prager E, Garbarino G, Dianzani U, Stockinger H, Malavasi F. 1998. Human CD38 (ADP-ribosyl cyclase) is a counter-receptor of CD31, an Ig superfamily member. J Immunol 160:395-402.
11. DeLisser H, Solomidou MC, Strieter R, Burdick M, Robinson C, Wexler R, Kerr J, Garlanda C, Merwin J, Madri J, Albelda S. 1997. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol 151:671-677.
12. Elias C, Spellberg J, Karan-Tamir B, Lin C, Wang Y, Kenna P, Muller W, Zukowski M, Andrew D. 1998. Ligation of CD31/PECAM-1 modulates the function of lymphocytes, monocytes and neutrophils. Eur J Immunol 28:1948-1958.
13. Evans PC, Taylor ER, Kilshaw PJ. 2001. Signaling through CD31 protects endothelial cells from apoptosis. Transplantation 71:457-460.
14. Ferrero E, Belloni D, Contini P, Foglieni C, Ferrero ME, Fabbri M, Poggi A, Zocchi MR. 2003. Transendothelial migration leads to protection from starvation-induced apoptosis in CD34+ CD14+ circulating precursors: Evidence for PECAM-1 involvement through Akt/PKB activation. Blood 101:186-193.
15. Gagescu R, Gruenberg J, Smythe E. 2000. Membrane dynamics in endocytosis: Structure-function relationship. Traffic 1:84-88.
16. Gao C, Sun W, Christofidou-Solomidou M, Sawada M, Newman DK, Bergom C, Albelda SM, Matsuyama S, Newman PJ. 2003. PECAM-1 functions as a specific and potent inhibitor of mitochondrial-dependent apoptosis. Blood 102:169-179.
17. Goldbaum FA, Leoni J, Wallach JC, Fossati CA. 1993. Characterization of an 18-kilodalton Brucella cytoplasmic protein which appears to be a serological marker of active infection of both human and bovine brucellosis. J Clin Microbiol 31:2141-2145.
18. Goldberger A, Middleton KA, Newman PJ. 1994. Changes in expression of the cell adhesion molecule PECAM-1 (CD31) during differentiation of human leukemic cell lines. Tissue Antigens 44:285-293.
19. Gordon C, Lloyd K. 1994. Endocytosis and recycling of gangliosides in a human melanoma cell line: Inhibitory effect of brefeldin A and monensin. Arch Biochem Biophys 315:339-344.
20. Guerra L, Mordoh J, Slavutsky I, Larripa I, Medrano EE. 1989. Characterization of IIB-MEL-J: A new and highly heterogenous human melanoma cell line. Pigment Cell Res 2:504-509.
21. Ilan N, Madri JA. 2003. PECAM-1: Old friend, new partners. Curr Opin Cell Biol 15:515-524.
22. Ilan N, Mohsenin A, Cheung L, Madri JA. 2001. PECAM-1 shedding during apoptosis generates a membrane-anchored truncated molecule with unique signaling characteristics. FASEB J 15:362-372.
23. Issekutz AC, Chuluyan HE, Lopes N. 1995. CD11/CD18-independent transendothelial migration of human polymorphonuclear leukocytes and monocytes: Involvement of distinct and unique mechanisms. J Leukoc Biol 57:553-561.
24. Jaffe EA, Nachman RL, Becker CG, Minick CR. 1973. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756.
25. Johnson JP. 1999. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev 18:345-357.
26. Kairiyama C, Slavutsky I, Larripa I, Morvillo V, Bravo AI, Bover L, Podhajcer OL, Mordoh J. 1995. Biologic, immunocytochemical, and cytogenetic characterization of two new human melanoma cell lines: IIB-MEL-LES and IIB-MEL-IAN. Pigment Cell Res 8:121-131.
27. Killisch I, Steinlein P, Romisch K, Hollinshead R, Beug H, Griffiths G. 1992. Characterization of early and late endocytic compartments of the transferrin cycle. Transferrin receptor antibody blocks erythroid differentiation by trapping the receptor in the early endosome. J Cell Sci 103:211-232.
28. Kirschbaum N, Gumina R, Newman P. 1994. Organization of the gene for human platelet/endothelial cell adhesion molecule-1 shows alternatively spliced isoforms and a functionally complex cytoplasmic domain. Blood 84: 4028-4037.
29. Koch N, Moldenhauer G, Hofmann WJ, Moller P. 1991. Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J Immunol 147:2643-2651.
30. Kohler G, Milstein C. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497.
31. Kulbe H, Levinson N, Balkwill F, Wilson J. 2004. The chemokine network in cancer-much more than directing cell movement. Int J Dev Biol 48:489-496.
32. Lastres P, Almendro N, Bellon T, Lopez-Guerrero JA, Eritja R, Bernabeu C. 1994. Functional regulation of platelet/endothelial cell adhesion molecule-1 by TGF-beta 1 in promonocytic U-937 cells. J Immunol 153:4206-4218.
33. Le TL, Yap AS, Stow JL. 1999. Recycling of E-cadherin: A potential mechanism for regulating cadherin dynamics. J Cell Biol 146:219-232.
34. Liao F, Ali J, Greene T, Muller W. 1997. Soluble domain 1 of platelet-endothelial cell adhesion molecule (PECAM) is sufficient to block transendothelial migration in vitro and in vivo. J Exp Med 185:1349-1357.
35. Mamdouh Z, Chen X, Pierini LM, Maxfield FR, Muller WA. 2003. Targeted recycling of PECAM from endothelial surface-connected compartments during diapedesis. Nature 421:748-753.
36. Marks MS, Woodruff L, Ohno H, Bonifacino JS. 1996. Protein targeting by tyrosine- and di-leucine-based signals: Evidence for distinct saturable components. J Cell Biol 35:341-354.
37. Miettinen M, Lindenmayer AE, Chaubal A. 1994. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens-evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol 7:82-90.
38. Muro S, Wiewrodt R, Thomas A, Koniaris L, Albelda SM, Muzykantov VR, Koval M. 2003. A novel endocytic pathway induced by clustering endothelial ICAM-1 or PECAM-1. J Cell Sci 116:1599-1609.
39. Nelissen I, Ronsse I, Van Damme J, Opdenakker G. 2002. Regulation of gelatinase B in human monocytic and endothelial cells by PECAM-1 ligation and its modulation by interferon-beta. J Leukoc Biol 71:89-98.
40. Newman PJ. 1997. The biology of PECAM-1. J Clin Invest 100:S25-S29.
41. Newman P. 1999. Switched at birth: A new family for PECAM-1. J Clin Invest 103:5-9.
42. Newman P, Berndt M, Gorski J, White G, Lyman S, Paddock C, Muller W. 1990. PECAM-1 (CD31) cloning and relation to adhesion molecules of the immunoglobulin gene superfamily. Science 247:1219-1222.
43. Newton J, Buckley C, Jones E, Simmons D. 1997. Residues on both faces of the first immunoglobulin fold contribute to homophilic binding sites of PECAM-1/CD31. J Biol Chem 272:20555-20563.
44. Newton JP, Hunter AP, Simmons DL, Buckley CD, Harvey DJ. 1999. CD31 (PECAM-1) exists as a dimer and is heavily N-glycosylated. Biochem Biophys Res Commun 261:283-291.
45. Newton-Nash D, Newman P. 1999. A new role for platelet-endothelial cell adhesion molecule-1(CD31): Inhibition of TCR-mediated signal transduction. J Immunol 163:682-688.
46. Ohno H, Stewart J, Fournier MC, Bosshart H, Rhee I, Miyatake S, Saito T, Gallusser A, Kirchhausen T, Bonifacino JS. 1995. Interaction of tyrosine-based sorting signals with clathrin-associated proteins. Science 269:1872-1875.
47. Orr FW, Wang HH, Lafrenie RM, Scherbarth S, Nance DM. 2000. Interactions between cancer cells and the endothelium in metastasis. J Pathol 190:310-329.
48. Pinter E, Barreuther M, Lu T, Imhof BA, Madri JA. 1997. Platelet-endothelial cell adhesion molecule-1 (PECAM-1/ CD31) tyrosine phosphorylation state changes during vasculogenesis in the murine conceptus. Am J Pathol 150:1523-1530.
49. Prager E, Sunder-Plassmann R, Hansmann C, Koch C, Kolter W, Knapp W, Stockinger H. 1996. Interaction of CD31 with a heterophilic counterreceptor involved in downregulation of human T cell responses. J Exp Med 184:41-50.
50. Prager E, Staffler G, Majdic O, Säemann M, Gódar S, Zlabinger G, Stockinger H. 2001. Induction of hyporesponsiveness and impaired T lymphocyte activation by the CD31 receptor: Ligand pathway in T cells. J Immunol 166:2364-2371.
51. RayChaudhury A, Elkins M, Kozien D, Nakada MT. 2001. Regulation of PECAM-1 in endothelial cells during cell growth and migration. Exp Biol Med (Maywood) 226:686-691.
52. Rival Y, Maschio AD, Rabiet M, Dejana E, Duperray A. 1996. Inhibition of platelet endothelial cell adhesion molecule-1 synthesis and leukocyte transmigration in endothelial cells by the combined action of TNF-α and IFN-γ. J Immunol 157:1233-1241.
53. Romer L, McLean N, Yan H, Daise M, Sun J, DeLisser H. 1995. IFN-α and TNF-γ induce redistribution of PECAM-1 (CD31) on human endothelial cells. J Immunol 154: 6582-6592.
54. Salamone MC, Mendiguren AK, Salamone GV, Fainboim L. 2001. Membrane trafficking of CD1c on activated T cells. J Leukoc Biol 70:567-577.
55. Sandoval I, Bakke O. 1994. Targeting of membrane proteins to endosome and lysosomes. Trends Cell Biol 4:292-297.
56. Santoso S, Orlova W, Song K, Sachs UJ, Andrei-Selmer CL, Chavakis T. 2005. The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J Biol Chem 280:36326-36333.
57. Sapino A, Bongiovanni M, Cassoni P, Righi L, Arisio R, Deaglio S, Malavasi F. 2001. Expression of CD31 by cells of extensive ductal in situ and invasive carcinomas of the breast. J Pathol 194:254-261.
58. Shawler DL, Johnson DE, McCallister TJ, Bartholomew RM, Dillman RO. 1988. Mechanisms of human CD5 modulation and capping induced by murine monoclonal antibody T101. Clin Immunol Immunopathol 47:219-229.
59. Stoscheck CM, Carpenter G. 1984. Down regulation of epidermal growth factor receptors: Direct demonstration of receptor degradation in human fibroblasts. J Cell Biol 98:1048-1053.
60. Tang D, Chen Y, Newman P, Shi L, Gao X, Diglio C, Honn K. 1993. Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J Biol Chem 268:22883-22894.
61. Treutiger C, Heddini A, Fernandez V, Muller W, Wahlgren M. 1997. PECAM-1/CD31, an endothelial receptor for binding Plasmodium falciparum-infected erythrocytes. Nature Medicine 3:1405-1408.
62. Voura EB, Chen N, Siu CH. 2000. Platelet-endothelial cell adhesion molecule-1 (CD31) redistributes from the endothelial junction and is not required for the transendothelial migration of melanoma cells. Clin Exp Metastasis 18:527-532.